H1N1 Vaccine Market Revenue, Insights, Overview, Outlook, Analysis | Valuates Reports
Built for executives and teams involved in growth planning, this research offers a data-driven view of the h1n1 vaccine industry’s direction and competitive environment.
What Is The Current Outlook For The H1N1 Vaccine Market?
The H1N1 vaccine market size has grown strongly in recent years. It will grow from $3.33 billion in 2024 to $3.52 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to previous influenza outbreaks, global health security concerns, vaccine development and approval processes, global vaccination campaigns, public health education initiatives, government funding and subsidies, pharmaceutical industry agility.
The H1N1 vaccine market size is expected to see strong growth in the next few years. It will grow to $4.69 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to research on broad-spectrum vaccines, global vaccine equity initiatives, public health resilience building, global health governance strengthening, integration of h1n1 vaccination with routine immunization. Major trends in the forecast period include global pandemic preparedness, influenza vaccination programs, vaccine development advances, cross-protection research, global health initiatives, technological improvements in vaccine manufacturing, production capacity expansion, data monitoring and surveillance.
Get your free sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7881&type=smp
What Are The Driving Factors Impacting The H1N1 Vaccine Market?
The increase in expenditure for research and development activities in the field of immunology and vaccine is expected to propel the growth of the H1N1 vaccine market going forward. Immunology and vaccines are used to prevent infections and help in producing antibodies to fight infections. Immunology is a crucial area of research in the medical and biological sciences that focuses on understanding the immune system. The H1N1 vaccine is a preparation used to boost antibody production, which provides immunity against a variety of diseases For instance, in March 2023, according to the National Institutes of Health (NIH), a US-based agency, Research supported by the NIH facilitated the rapid development of mRNA COVID-19 vaccines. By March 2022, more than 577 million doses had been administered in the United States, resulting in an estimated 2.4 million lives saved and preventing 17 million hospitalizations. Therefore, increasing expenditure for research and development activities in the field of immunology and vaccines is driving the growth of the H1N1 vaccine market.
Analysis Of Major Segments Driving The H1N1 Vaccine Market Growth
The h1n1 vaccine market covered in this report is segmented –
1) By Product Type: Inactivated Vaccine, Live Attenuated Vaccine
2) By Route Of Administration: Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination
3) By End Users: Hospitals, Clinics, Research And Diagnostic Laboratories, Other End Users
Subsegments:
1) By Inactivated Vaccine: Injectable Inactivated Vaccine, Intranasal Inactivated Vaccine
2) By Live Attenuated Vaccine: Injectable Live Attenuated Vaccine, Intranasal Live Attenuated Vaccine
What Are The Upcoming Trends Of H1N1 Vaccine Market In The Globe?
Strategic collaborations between companies is a key trend that is gaining popularity in the H1N1 (swine flu) vaccination market. Companies in the H1N1 (swine flu) Vaccination market are focusing on strategic collaborations to expand their market share. For instance, in August 2022, a significant pharmaceutical company and Open Orphan affiliate hVIVO have agreed to an agreement for $123 million to create a brand-new batch of H1N1 influenza challenge virus. This has stimulated the growth potential of both companies in the industry.
Which Are The Top Players Involved In H1N1 Vaccine Market?
Major companies operating in the H1N1 vaccine market are Sanofi SA, GlaxoSmithKline PLC, CSL Limited, AstraZeneca Inc., Zydus Lifesciences Limited, Merck and Co.Inc., Novavax Inc., Panacea Biotec Ltd., Sinovac Biotech Ltd., Green Cross Corp., Pfizer Inc., Seqirus Ltd., Cipla Inc., Protein Sciences Corporation, Hualan Biological Engineering Inc., Changsheng Bio-Technology Co. Ltd., Bharat Biotech International Limited, Serum Institute of India Pvt. Ltd., Bio Farma Group, PT Kalbe Farma Tbk, Moderna Inc., CureVac NV, BioNTech SE, Inovio Pharmaceuticals Inc., Vaxart Inc., Altimmune Inc., Dynavax Technologies Corporation, VBI Vaccines Inc., GeoVax Labs Inc.
View the full h1n1 vaccine market report here:
https://www.thebusinessresearchcompany.com/report/h1n1-vaccine-global-market-report
Which Region Drives The Most Demand In The H1N1 Vaccine Market?
North America was the largest region in the H1N1 vaccine market in 2024. The regions covered in the H1N1 vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
#Contact Us:#
The Business Research Company
Market Research Reports
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
#Follow Us On:#
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment